Thursday, 20 December 2012

Kyambogo graduates oblivious of employment

RACHEAL NINSIIMA
Majority of the 6983 graduates of Kyambogo University’s ninth graduation are uncertain of where they are going to earn a living. As the guest of honour, Hon Jessica Alupo delivered her speech; they chanted ‘give us jobs’ showcasing their fears.
“I hope to get a job early next year because I don’t want to sit home with my first class,” Teddy Nanteza who graduated with a first class honours degree in Economics and Statistics said.
Moses Okoth wants to establish himself as an academician but is uncertain of which institution to work in. He says the employment system is crippled by attaining jobs by ‘technical know who’ instead of meritorious recruitment. He graduated with a first class honours degree in Micro finance. 
 
 However despite the uncertainty of employment after university education, the university continues to attract over 30,000 applications against only 7000 positions offered in the 111 programmes.
“The opportunity to increase admissions is premised on expanded facilities and increased funding,” Prof John Asibo Opuda, Ag Vice Chancellor said during the ceremony.
Of the graduates, 13 obtained PhD degrees bringing the number of PhDs degree holders to 40 since 2008. There were 28 masters’ candidates, 52 post graduate diplomas and six pioneer Master of Science in Physics graduates. 

Meanwhile, Government in partnership with the African Development Bank have put in place a $28m project to help in the construction of a 7000-seater library, modern laboratories, ICT infrastructure and further technical teacher education development.
ninsiima@observer.ug

Sunday, 16 December 2012

NaCRRI receives funding to promote cassava breeding


RACHEAL NINSIIMA

The Bill and Melinda Gates Foundation and the Department for International Development of the United Kingdom (DFID) are investing $25.2M (about shs655b) to improve the cassava’s productivity, build human and technical capacity for plant breeding in sub-Saharan Africa. This is because the tough woody plant is predicted to be one of the few crops that will benefit from climate change as it can withstand drought, marginal soils and long-term underground storage.

The five-year project is being hosted by Cornell University in the US with five partner institutions: the National Crops Resources Research Institute (NaCRRI) in Uganda, National Root Crops Research Institute (NRCRI) and the International Institute of Tropical Agriculture (IITA) in Nigeria, Boyce Thompson Institute (BTI) for Plant Research in New York and US Department of Energy Joint Genome Institute of the Lawrence Berkeley National Laboratory, in California.

“Increased support for strengthening the research capacity in Africa and harnessing novel technologies are critical to improving overall agricultural productivity and food security for poor people,” said Yona Baguma, project coordinator for NaCRRI.

Cassava breeding is typically a lengthy process; it takes almost a decade to multiply and release a new variety. Using the new technological process of genomic selection (statistical modeling to predict cassava performance before field testing and dramatically accelerates the breeding cycle) new releases of cassava could be ready in as little as six years.

The partners will share cassava data, expertise, and information on a publicly available website www.cassavabase.org . In addition to using the latest genomic information, project partners will also hold awareness-building workshops for farmers, scholars, researchers and policy makers.

ninsiima@observer.ug




Wednesday, 12 December 2012

Blood clots in the veins may lead to abrupt deaths


BY RACHEAL NINSIIMA
For weeks, the universe did not seem to make sense to Musa Mugume who had sustained fractures in his legs and suffered severe bleeding from a bus accident that had occurred along Masaka road. The illness appeared not to affect his general physique but he did notice a strange symptom; that of a swelling in his left leg.

Mustering courage, he let it be massaged every day for two hours because casts had to be put on his legs. When they finally placed, pain seemed to surge beneath these fibre tight bone straighteners. However, after days on end, they were finally removed. When the orthopaedic did an ultra-scan on his legs, he diagnosed Deep Vein Thrombosis (DVT). Unbeknown to him, his life would lay motioneless and breathless in just three days. Mugume died of a deep clot in his blood.

DVT means thrombosis (clotting) of blood in the deep veins of the legs. It can cause swelling and pain in the leg, but often occurs without giving any symptoms. Dr Miriam Laker Opwonya-Oketta of the infectious disease institute says that blood clots may form abnormally when there is a reduction in the speed of the normal flow of blood in the veins, injury in the inner walls of the blood vessels and abnormalities in the substances which are responsible for forming clots.

Dr Miriam says that there are two systems of veins in the legs - the important deep veins which carry most of the blood up the legs towards the heart and the superficial veins just under the skin.She adds that a blood clot/thrombus in the deep venous system is not dangerous but may cause pain. 

“The situation becomes life threatening when a piece of clot breaks off, travels to the hearts and is pumped into blood vessels of the lings,” she says.
She adds that all the veins in the leg have valves which should direct blood flow upwards, towards the heart. The deep veins lie between the muscles, and muscular activity (moving the legs, walking, or any leg exercise) helps to pump the blood up these veins. 

When the legs are inactive, and particularly when sitting or standing, blood tends to stagnate in the deep veins. Stagnation of blood can eventually lead to thrombosis.

Dr Derrick Bengo, a haematologist (blood specialist)at Mulago hospital explains thatwhen the clot moves up to the lungs, a person might develop one of these three complications.

Pulmonary embolism.
A pulmonary embolism happens when a piece of the blood clot breaks off and travels through your bloodstream to your lungs, where it blocks one of the blood vessels.Dr Bengo says that small pulmonary emboli may cause chest pain, and sometimes coughing of blood while the multiple or larger pulmonary emboli may cause death.
“The thrombosis can get stuck and interfere with the process of gas exchange resulting into death,” he says.
Post thrombotic syndrome
This happens if the damage caused by a DVT permanently reduces the ability of your veins to efficiently return blood from your lower leg and leads to pooling of fluid. This can eventually lead to long-term pain and swelling. In severe cases these may lead to boils on your leg.
Limb ischaemia
This is a rare complication that only happens with a large DVT. The blood clot can cause the pressure in your vein to become high. “This can block the flow of blood through your arteries, so less oxygen is carried to your affected leg. This can be painful and lead to skin boils, infection and even decay,” Dr Bengo says.

Treatment of DVT
Inthe medical journal, ‘The Diagnosis of venous thromboembolism,’Kelly J and Lewis RR in advise thatanticoagulant medicines prevent a blood clot from getting bigger and also help stop part of the blood clot from breaking off and becoming lodged in another part of one’s bloodstream. There are two types of anticoagulants used in treatment of DVT. These are:
Heparins
Heparin is available in two different forms: standard and low molecular weight heparin (LMWH). Standard heparin can be given as an intravenous injection administered straight into one of your veins, anintravenous infusion where a continuous drip of heparin is fed through a narrow tube into a vein in your arm and a subcutaneous injection, administered under your skin. LMWH works contains small molecules that dissolve the clot which means you will not have to stay in hospital and be monitored.
Warfarin
Warfarin is taken as a tablet. You may need to take it after an initial heparin treatment to prevent further blood clots occurring.
“When you first start taking warfarin, you may need to have two to three blood tests a week until your regular dose is decided,” they write.
In addition, Dr Bengo advises that individuals with an excessive tendency to form blood clots, anticoagulant drugs like warfarin can be lifesaving.
Elastic compression stockings
Patients with a deep vein thrombosis should wear compression stockings as the rate of post-thrombotic syndrome may be reduced.These special stockings are designed to provide "graduated" pressure starting at the ankle and reducing pressure as the stocking goes up to the calf or thigh. By providing "graduated" compression with the greatest pressure at the ankle and reducing pressure as the stocking goes up to the calf or thigh - medical compression stockings support the weakened vein walls.
In terms of dieting, vitamin K is best known for its role in healthy blood clotting.In 1929 a Danish scientist discovered thatoften, when a person is known to have a slow blood clotting time and were given Vitamin K before surgery, it controlled excess bleeding.
The use of the letter "K" in the very name of this vitamin originally came from the German word koagulation.
“Leafy vegetableslike spinach and amaranathus containVitamin Kanthocyanins – powerful amino acids that may cut one’s risk of heart disease and stroke by inhibiting clot formation,”Grace Babughirana an expert nutritionist says.
Babughirana adds that other food sources include beef liver, chicken liver, milk and eggs and liver.
On the Knee guru website, one post reads:“I had experience with a blood clot after my surgery. It is not something that you want to mess around with. The discomfort is like a deep ache. It lessens when you elevate the leg and becomes more uncomfortable when you are upright. If you continue to be concerned- call your doctor. It's always better to be safe than sorry.”
Although its symptoms and signs do not come in handy like other ailments, DVT could be lead to sudden death like that Mugume faced.
ninsiima@observer.ug

Monday, 10 December 2012

Palliative care eases pain but challenged


RACHEAL NINSIIMA
Norah Nanziri’s days have fallen short of pain. As she lies on a crowded mattress at her home in Makindye, she is at ease telling the story of her life from illness to recovery. The 40-year-old is currently undergoing palliative care for advanced rectal cancer.
“Before I started receiving this kind of treatment, I had a lot of pain passing out waste and sometimes, I passed out only blood and pus,” Nanziri narrates,
“In fact, I used to hold onto walls for hours when I was easing myself.” 
After rounds to Nsambya and Mulago hospitals yielded no relief, Nanziri finally settled for Hospice Clinic in Makindye where she was given free chemotherapy and Morphine, a drug for controlling severe pain. She even underwent spiritual and psychological rejuvenation through prayers and counselling.
Today, Nanziri can sit upright and easily excretes notwithstanding the pain she lived with for a year. 


The World Health Organization defines palliative care as an approach that improves the quality of a patient’s life facing problems associated with life threatening illnesses through early identification and treatment of physical, psychosocial and spiritual pain. It’s usually availed to cancer and HIV/AIDS patients. Such treatment, while not curative, prolongs life for a considerable period of time and restores the quality of life.
However, access to life saving medicines like Morphine for palliative care patients like Nanziri, is now threatened by anti counterfeiting laws. This was revealed last week during the launch of ‘The Development of Palliative Care in Uganda’ report in Kampala.
“This is increasingly happening through the enactment of legislation in East Africa ostensibly to fight counterfeits but is in actual sense tightening enforcement of intellectual property rights as a step towards banning generic drugs,” Binaifer Nowrojee, the director of the Open Society Initiative for East Africa (OSIEA) said.
Kenya enacted such a law in 2008 and the East African community is considering a regional law that will supersede national laws on anti counterfeiting.
Nowrojee added that the problem of poor quality medicines will not be contained by enlarging the application of intellectual property rights in order to ban generic medicines. Rather, regulatory services need to be strengthened to oversee the quality, safety and efficacy of medicines on the market.

Palliative care in Uganda


With an increase in of HIV (130,000 new infections annually) and cancer in Uganda, the need for palliative care is on the rise.
“No human right affects us as much as health and caring for people with lifelong illnesses is a universal challenge. We all need comfort, dignity and freedom from debilitating physical pain and this is what palliative care ensures,” Nowrojee says.
The need for palliative care is intensified by the fact that the health care system is underfunded with government expenditure providing $1.67(about Shs 5,000) per person annually and yet the ministry needs at least $4 (about Shs10, 000)
According to Rose Kiwanuka, the country director for the Palliative Care Association of Uganda (PCAU), there is a wide gap between health care services in rural and urban areas and hence the need to extend coverage for palliative care.
Among the factors slowing down palliative care service provision in Uganda are: inadequate trained health professionals, lack of clear understanding and targets for palliative care, inadequate awareness, support and training institutions.
“Palliative care development requires policies covering the training of health workers, ensuring that they are legally allowed to prescribe opioids including morphine and integration of the care into the country’s mainstream clinical services,” Dr Jacinto Amandua the commissioner of Clinical services in the Ministry of Health says.

History
Management of severe pain and symptoms among cancer and HIV/AIDS patients started in 1993 when Dr Anne Merriman, on a feasibility study for a model hospice, introduced palliative care services.
In the same year, government imported oral Morphine and services were first delivered at Nsambya Hospital. Expansion of these services beyond Kampala started in 1998 with the establishment of Mobile Hospice Mbarara (MHM) and Little Hospice Hoima (LHH).
Today, palliative care is spread in over 61 districts and at least one health facility in each region provides the service.
Despite the absence of a stand-alone palliative care policy, palliative care is recognized as an essential clinical service with strategies for expansion in the 2010 Health Sector Strategic investment Plan (HSSIP).